About Pieris Pharma (PIRS)
Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-op... Read more
- USD10.98
- USD11.20
- USD10.60
- USD80.80
- -20.50%
- 43M
- 31.51k
- 24.18k
- 14M
- 10.60
- -83.10%
Stock News
3 hours ago
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It Soared 1,700% in 2 Years, and Wall Street Says the Stock Is Still a Buy
Yahoo
3 hours ago
Q1 2024 Newpark Resources Inc Earnings Call
Yahoo
3 hours ago
Most Investors Think They're Boring Companies. But These 2 Businesses Are Unstoppable and Are Reaching New Highs in 2024.
Yahoo
4 hours ago
2 Energy Stocks That Are Screaming Buys in May
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
